Status:

COMPLETED

The Effects of Inhaled Nitric Oxide After Fontan Operation

Lead Sponsor:

Ellen Spurrier

Collaborating Sponsors:

Mallinckrodt

Conditions:

Congenital Heart Defect

Eligibility:

All Genders

1-5 years

Phase:

PHASE2

PHASE3

Brief Summary

Pleural effusions continue to be a post-operative complication seen after Fontan operation. This study will examine the use inhaled nitric oxide (iNO) given for 54 hours after Fontan operation to impr...

Eligibility Criteria

Inclusion

  • Male/female patients
  • Undergoing Fontan operation at the Nemours Cardiac Center at A. I. duPont Hospital for Children
  • Written parental permission to participate in this research study

Exclusion

  • Any condition which the PI feels will interfere with the patient's safe and effective participation

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT00945529

Start Date

February 1 2008

End Date

December 1 2011

Last Update

May 19 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

A. I. duPont Hospital for Children/Nemours Cardiac Center

Wilmington, Delaware, United States, 19803